DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Alora (Estradiol Transdermal) - Published Studies

 
 



Alora Related Published Studies

Well-designed clinical trials related to Alora (Estradiol Transdermal)

Pharmacokinetics of testosterone and estradiol gel preparations in healthy young men. [2013]

Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial. [2011.11.29]

Naproxen or estradiol for bleeding and spotting with the levonorgestrel intrauterine system: a randomized controlled trial. [2011.09.24]

Prevention of menstrual migraine with perimenstrual transdermal 17-beta-estradiol: a randomized, placebo-controlled, double-blind crossover study. [2011.08]

Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition. [2011.07]

[Influence of estradiol administration mode on plasma insulin-like growth factor-I (IGF-I) and its binding proteins 1 and 3 concentration in postmenopausal women treated with norethisterone acetate]. [2011.03]

Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial. [2011]

Clinical usefulness of a low-dose maintenance therapy with transdermal estradiol gel in Japanese women with estrogen deficiency symptoms. [2011]

Transdermal estradiol and oral or vaginal natural progesterone: bleeding patterns. [2010.10]

Effects of transdermal estradiol gel and oral tibolone on health-related quality of life after surgical menopause. [2010.09]

Gabapentin vs. low-dose transdermal estradiol for treating post-menopausal women with moderate to very severe hot flushes. [2010.05]

Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp. [2010.01]

Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp. [2010]

Effects of variations in serum estradiol concentrations on secretory endometrial development and function in experimentally induced cycles in normal women. [2009.12]

Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: a randomized controlled trial. [2009.10]

Steady-state pharmacokinetics following application of a novel transdermal estradiol spray in healthy postmenopausal women. [2009.09]

Low-dose transdermal estradiol induces breast density and heterogeneity changes comparable to those of raloxifene. [2009.07]

[Effects and safety of gonadotrophin-releasing hormone agonist combined with estradiol patch and oral medroxyprogesterone acetate on endometriosis] [2009.07]

Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trial. [2009.05]

Effect of raloxifene and low-dose percutaneous 17beta-estradiol on menopause symptoms and endometrium-A randomized controlled trial. [2009.01.20]

Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women. [2009.01]

Effects of either tibolone or continuous combined transdermal estradiol with medroxyprogesterone acetate on coagulatory factors and lipoprotein(a) in menopause. [2009]

Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial. [2008.12]

Estradiol treatment and its interaction with the cholinergic system: Effects on cognitive function in healthy young women. [2008.11]

Metabolic syndrome in postmenopausal women: the influence of oral or transdermal estradiol on inflammation and coagulation markers. [2008.11]

Transdermal estradiol reduces F2alpha-isoprostane levels in postmenopausal women. [2008.07]

Low-dose estradiol spray to treat vasomotor symptoms: a randomized controlled trial. [2008.06]

A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women. [2008.05]

The effect of ultralow-dose transdermal estradiol on sexual function in postmenopausal women. [2008.03]

Pharmacokinetic interaction between ethinyl estradiol, norethindrone and darunavir with low-dose ritonavir in healthy women. [2008]

Endogenous estrogen levels and the effects of ultra-low-dose transdermal estradiol therapy on bone turnover and BMD in postmenopausal women. [2007.11]

A prospective randomized comparative study of the effects of intranasal and transdermal 17 beta-estradiol on postmenopausal symptoms and vaginal cytology. [2007.10]

Lowest Effective Transdermal 17{beta}-Estradiol Dose for Relief of Hot Flushes in Postmenopausal Women: A Randomized Controlled Trial. [2007.10]

Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women. [2007.08]

One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women. [2007.06.20]

A clinical trial of 3 doses of transdermal 17beta-estradiol for preventing postmenopausal bone loss: a preliminary study. [2007.05]

Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women. [2007.05]

Simultaneous estradiol and levonorgestrel transdermal delivery from a 7-day patch: in vitro and in vivo drug deliveries of three formulations. [2007.04]

Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial. [2007.03]

Exogenous oestradiol and progesterone administration does not cause oedema in healthy young women. [2007.03]

[Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol] [2007]

Well-designed clinical trials possibly related to Alora (Estradiol Transdermal)

Testosterone replacement therapy in older male subjective memory complainers: double-blind randomized crossover placebo-controlled clinical trial of physiological assessment and safety. [2015]

Vasomotor hot flashes and heart rate variability: a placebo-controlled trial of postmenopausal hormone therapy. [2011.09.19]

Acute testosterone deprivation reduces insulin sensitivity in men. [2011.07.29]

A randomized trial of microdose leuprolide acetate protocol versus luteal phase ganirelix protocol in predicted poor responders. [2011.06.30]

Hormonal replacement therapy does not affect self-estimated pain or experimental pain responses in post-menopausal women suffering from fibromyalgia: a double-blind, randomized, placebo-controlled trial. [2011.03]

Transdermal estrogen therapy effects on fibrinogen levels in women with a past history of venous thromboembolism: a pilot study. [2011]

Beneficial influence of postmenopausal estrogen therapy on serum adhesion molecules is independent of the route and dose of administration. [2011]

Physiological versus standard sex steroid replacement in young women with premature ovarian failure: effects on bone mass acquisition and turnover. [2010.12]

Effects of estrogen and testosterone on resting energy expenditure in older men. [2010.12]

Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial. [2010.11.16]

Endometrial effect of progesterone delivered by vaginal rings in estrogen-treated postmenopausal women. [2010.10]

Hot flushes and biochemical markers for cardiovascular disease: a randomized trial on hormone therapy. [2010.10]

Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy. [2010.07]

Effectiveness of hormone therapy for treating dry eye syndrome in postmenopausal women: a randomized trial. [2010.06]

Age in men does not determine gonadotropin-releasing hormone's dose-dependent stimulation of luteinizing hormone secretion under an exogenous testosterone clamp. [2010.06]

Effect of dienogest on estrogen-induced nitric oxide production in human umbilical vein endothelial cells and endothelium-dependent vasodilatation in postmenopausal women. [2010.05]

The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women. [2010.05]

Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. [2010.04]

Hormone therapy in Brazilian postmenopausal women with chronic hepatitis C: a pilot study. [2010.04]

Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study. [2010.03]

Effects of exogenous testosterone supplementation in gonadotrophin stimulated cycles. [2010.03]

Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal women. [2010.02]

Effect of non-oral estrogen on risk markers for metabolic syndrome in early surgically menopausal women. [2010.02]

Sexual function in first-time contraceptive ring and contraceptive patch users. [2010.01]

[Combined hormonal contraception in cycles artificially extended]. [2010.01]

Is placebo as effective as estrogen regimens on vasomotor symptoms in women with surgical menopause? [2010]

Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy. [2010]

Age in men does not determine gonadotropin-releasing hormone's dose-dependent stimulation of luteinizing hormone secretion under an exogenous testosterone clamp. [2010]

Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal women. [2010]

Effect of hot flushes on vascular function: a randomized controlled trial. [2009.10]

Growth hormone and sex steroid effects on serum glucose, insulin, and lipid concentrations in healthy older women and men. [2009.10]

Influence of transdermal rotigotine on ovulation suppression by a combined oral contraceptive. [2009.09]

Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women. [2009.09]

Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). [2009.09]

Effects of estrogen replacement therapy on estrogen receptor expression and immunoregulatory cytokine secretion in surgically induced menopausal women. [2009.07]

Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. [2009.05]

Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo. [2009.05]

Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction. [2009.04]

Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial. [2009.02.20]

Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial. [2009.02]

Hormone therapy for endometriosis and surgical menopause. [2009.01.21]

Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia. [2009.01]

Effects of long-term transdermal hormone replacement therapy on the renin-angiotensin- aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women. [2008.12]

Estrogen replacement therapy decreases plasma adiponectin but not resistin in postmenopausal women. [2008.11]

Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study. [2008.11]

Estrogen elevates the peak overnight production rate of acylated ghrelin. [2008.11]

Endometrial development and function in experimentally induced luteal phase deficiency. [2008.10]

Estrogen supplementation selectively enhances hypothalamo-pituitary sensitivity to ghrelin in postmenopausal women. [2008.10]

Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. [2008.09]

Estrogen in severe mental illness: a potential new treatment approach. [2008.08]

Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins. [2008.08]

Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial. [2008.08]

Early hormonal data from a multicentre phase II trial using transdermal oestrogen patches as first-line hormonal therapy in patients with locally advanced or metastatic prostate cancer. [2008.08]

Postmenopausal estrogen therapy modulates nocturnal nonlinear heart rate dynamics. [2008.07]

Use of luteal estrogen supplementation in normal responder patients treated with fixed multidose GnRH antagonist: a prospective randomized controlled study. [2008.06]

Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA. [2008.05]

One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu. [2008.04.20]

Estrogen, medroxyprogesterone acetate, endothelial function, and biomarkers of cardiovascular risk in young women. [2008.04]

Effect of oral and transdermal hormone therapy on hyaluronic acid in women with and without a history of intrahepatic cholestasis of pregnancy. [2008.04]

Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial. [2008.03]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017